Download PDF
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2020; 17(04): 232-235
DOI: 10.1055/a-1202-6536
Aktuell diskutiert

Empfehlungen der Österreichischen Gesellschaft für Senologie – Nachsorge nach Mammakarzinom

Michael Stierer
1   PK Döbling, Brustzentrum Wien, Vorstandsmitglied der ÖGS
,
Rupert Bartsch
2   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 1, Klinische Abteilung für Onkologie, Mitglied des wissenschaftlichen Beirats der ÖGS
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

In zahlreichen Studien konnte gezeigt werden, dass die Verabreichung einer systemischen Therapie nach erfolgter Lokaltherapie zur Verbesserung des Gesamtüberlebens führt. [1]

Im Gegensatz dazu konnte bis jetzt aber nicht schlüssig bewiesen werden, dass ein frühzeitiger Therapiebeginn zum Zeitpunkt des Auftretens asymptomatischer Metastasen die Überlebenszeit signifikant verlängert. [2] [3] Lediglich die frühzeitige Entdeckung eines Lokalrezidivs sowie eines kontralateralen Karzinoms führt zur Prognoseverbesserung, sodass aus dieser Sicht eine obligate apparative Nachsorge bis auf die Mammografie und den Brustultraschall nicht notwendig erscheint beziehungsweise nicht generell empfohlen werden kann [4].



Publication History

Article published online:
15 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of chemotherapy and Hormonal therapy for early breast cancer recurrence and 15 year survival: an overview of the randomized trials. Lancet 2005; 365: 1687
    CrossrefPubMedGoogle Scholar
  • 2 Grunfeld E. et al. Randomized trial of long-term follow-up for early stage breast cancer: A comparision of family physician versus specialist care. J Clin Oncol 2006; 24: 848
    CrossrefPubMedGoogle Scholar
  • 3 Runowicz CD. et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol 2016; 34: 611
    CrossrefPubMedGoogle Scholar
  • 4 Houssami N, Ciatto S. Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective?. Breast 2010; 19: 439
    CrossrefPubMedGoogle Scholar
  • 5 Ribelles N. et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. Breast Cancer Res 2013; R98: 15
    PubMedGoogle Scholar
  • 6 Goldhirsch A. et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer. Ann Oncol 2007; 18: 1133
    CrossrefPubMedGoogle Scholar
  • 7 Perou CM. et al. Molecular portraits of human breast tumors. Nature 2000; 406: 747
    CrossrefPubMedGoogle Scholar
  • 8 Cheang MCH. et al. KI 67 Index, Her2 Status and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009; 101: 736
    CrossrefPubMedGoogle Scholar
  • 9 Winchester D. et al. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 1979; 43: 956
    CrossrefPubMedGoogle Scholar
  • 10 Kubista E. et al. Empfehlungen zur Nachsorge nach Mammakarzinom. Senologie 2007; 3: 158
    PubMedGoogle Scholar
  • 11 AGO Guidelines Breast Version 2018. www.ago-online.de
    PubMedGoogle Scholar
  • 12 Bich U, Helbich T. Follow-up of patient with breast cancer: Imaging of local recurrence and distatant metastases. In: Hodler H. et al. (eds.) Diseases of the Chest, Breast, Heart and Vessels 2019–2022. IDKD Springer Series; DOI: https://doi.org/10.1007/978-3-030-11149-6_14
    CrossrefGoogle Scholar
  • 13 Saslow D. et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 75
    CrossrefPubMedGoogle Scholar
  • 14 Nemanic S. et al. Comparison of thoracic radiographs and single breat-hold helical CT for detection fo pulmonary nodules in dogs with metastatic neoplasia. J Vet Intern Med 2006; 20: 508
    CrossrefPubMedGoogle Scholar
  • 15 Yoon JH, Kim MJ, Kim EK. et al. Imaging surveillance of patients with breast cancer after primary treatment: current recommendations. KJR 2015; 16: 219-228
    PubMedGoogle Scholar
  • 16 Moy L, Bailey L, D’Orsi C. et al. ACR appropriateness criteria stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. J AmColl Radiol 2017; 14: S282-S292
    CrossrefPubMedGoogle Scholar
  • 17 NCCN Guidelines Breast Cancer version 4.2018. www.nccn.org
    PubMedGoogle Scholar
  • 18 GIVIO Investigators. Impact of follow-up and testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 1994; 271: 1587
    CrossrefPubMedGoogle Scholar
  • 19 Roselli Del Turco M. et al. Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial. JAMA 1994; 271: 1593
    CrossrefPubMedGoogle Scholar
  • 20 Vlastos G. et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004; 11: 869
    CrossrefPubMedGoogle Scholar
  • 21 Rolle A. et al. Is surgery for multiple lung metastases reasonable? A total of 328 consecutive patients with multiple laser metastasectomies with a new 1318-mm Nd: YAG laser. J Thorac Cardiovasc Surg 2006; 131: 1236
    CrossrefPubMedGoogle Scholar
  • 22 Chua TC. et al. Hepatic resection for metastatic breast cancer: A systematic review. Eur J Cancer 2011; 47: 2282
    CrossrefPubMedGoogle Scholar
  • 23 Stierer M. Evidence-based follow-up for breast cancer. short review memo 2020; 13: 60
    PubMedGoogle Scholar